# Epigenetic Impact of Sleep Timing in Children: Novel DNA Methylation Signatures via SWAG Analysis

**Authors:** Erika Richter, Priyadarshni Patel, Yagmur Y. Ozdemir, Ukamaka V. Nnyaba, Roberto Molinari, Jeganathan R. Babu, Thangiah Geetha

PMC · DOI: 10.3390/ijms262110615 · International Journal of Molecular Sciences · 2025-10-31

## TL;DR

This study finds that children's bedtime affects DNA methylation patterns, which may influence metabolism and development through epigenetic changes.

## Contribution

The study introduces novel DNA methylation signatures linked to sleep timing in children using the SWAG algorithm.

## Key findings

- 1006 CpG sites across 571 genes showed significant methylation differences between early and late bedtime groups.
- Key genes like ABCG2 and CDH4 were linked to circadian rhythm and metabolic processes.
- Overlap with sleep and obesity gene sets suggests long-term developmental and metabolic risks.

## Abstract

Pediatric obesity is rising globally, and emerging evidence suggests that sleep timing may influence metabolic health through epigenetic mechanisms. This study investigated epigenome-wide DNA methylation patterns associated with bedtime in children and explored their biological relevance. Children aged 6–10 years were classified as early (≤8:30 PM) or late (>8:30 PM) bedtime groups. Saliva-derived DNA was analyzed using the Illumina Infinium MethylationEPIC BeadChip Array, and the Sparse Wrapper Algorithm (SWAG) was applied to identify differentially methylated loci. A total of 1006 CpG sites, representing 571 unique genes, were significantly associated with bedtime (p < 0.001). Significant methylation differences were observed between early and late bedtime groups, with ABCG2, ABHD4, MOBKL1A, AK3, SDE2, PRAMEF4, CREM, CDH4, BRAT1, and SDK1 showing the most consistent variation. Functional enrichment analyses (Gene Ontology, KEGG, and DisGeNET) conducted on the SWAG-identified gene set revealed enrichment in biological processes including peptidyl-lysin demethylation, regulation of sodium ion transport, DNA repair, and lipo-protein particle assembly. Key KEGG pathways included circadian entrainment, neurotransmission (GABAergic, dopaminergic, and glutamatergic), growth hormone synthesis, and insulin secretion. DisGeNET analysis identified associations with neurodevelopmental disorders and cognitive impairment. Cross-comparison with established sleep and obesity gene sets identified ten overlapping genes(CDH4, NR3C2, ACTG1, COG5, CAT, HDAC4, FTO, DOK7, OCLN, and ATXN1). These findings suggest that variations in bedtime during childhood may epigenetically modify genes regulating circadian rhythm, metabolism, neuronal connectivity, and stress response, potentially predisposing to later-life developmental, and metabolic challenges.

## Linked entities

- **Genes:** ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429], ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B) [NCBI Gene 63874], MOB1B (MOB kinase activator 1B) [NCBI Gene 92597], AK3 (adenylate kinase 3) [NCBI Gene 50808], SDE2 (spliceosome associated SDE2) [NCBI Gene 163859], PRAMEF4 (PRAME family member 4) [NCBI Gene 400735], CREM (cAMP responsive element modulator) [NCBI Gene 1390], CDH4 (cadherin 4) [NCBI Gene 1002], BRAT1 (BRCA1 associated ATM activator 1) [NCBI Gene 221927], SDK1 (sidekick cell adhesion molecule 1) [NCBI Gene 221935], NR3C2 (nuclear receptor subfamily 3 group C member 2) [NCBI Gene 4306], ACTG1 (actin gamma 1) [NCBI Gene 71], COG5 (component of oligomeric golgi complex 5) [NCBI Gene 10466], CAT (catalase) [NCBI Gene 847], HDAC4 (histone deacetylase 4) [NCBI Gene 9759], FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068], DOK7 (docking protein 7) [NCBI Gene 285489], OCLN (occludin) [NCBI Gene 100506658], ATXN1 (ataxin 1) [NCBI Gene 6310]

## Full-text entities

- **Genes:** PRAMEF4 (PRAME family member 4) [NCBI Gene 400735], AK3 (adenylate kinase 3) [NCBI Gene 50808] {aka AK3L1, AK6, AKL3L, AKL3L1, FIX}, ACTG1 (actin gamma 1) [NCBI Gene 71] {aka ACT, ACTG, DFNA20, DFNA26, HEL-176}, MOB1B (MOB kinase activator 1B) [NCBI Gene 92597] {aka MATS2, MOB4A, MOBKL1A}, BRAT1 (BRCA1 associated ATM activator 1) [NCBI Gene 221927] {aka BAAT1, C7orf27, NEDCAS, RMFSL}, ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B) [NCBI Gene 63874] {aka ABH4}, SDK1 (sidekick cell adhesion molecule 1) [NCBI Gene 221935], CAT (catalase) [NCBI Gene 847], OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, CDH4 (cadherin 4) [NCBI Gene 1002] {aka CAD4, R-CAD, RCAD}, NR3C2 (nuclear receptor subfamily 3 group C member 2) [NCBI Gene 4306] {aka MCR, MLR, MR, NR3C2VIT}, ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429] {aka ABC15, ABCP, BCRP, BMDP, CD338, CDw338}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, SDE2 (spliceosome associated SDE2) [NCBI Gene 163859] {aka C1orf55, dJ671D7.1}, CREM (cAMP responsive element modulator) [NCBI Gene 1390] {aka CREM-2, ICER, hCREM-2}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, ATXN1 (ataxin 1) [NCBI Gene 6310] {aka ATX1, D6S504E, SCA1}, HDAC4 (histone deacetylase 4) [NCBI Gene 9759] {aka AHO3, BDMR, HA6116, HD4, HDAC-4, HDAC-A}, COG5 (component of oligomeric golgi complex 5) [NCBI Gene 10466] {aka CDG2I, GOLTC1, GTC90}, DOK7 (docking protein 7) [NCBI Gene 285489] {aka C4orf25, CMS10, CMS1B}
- **Diseases:** cognitive impairment (MESH:D003072), obesity (MESH:D009765), Sleep (MESH:D012893), neurodevelopmental disorders (MESH:D002658)
- **Chemicals:** sodium (MESH:D012964)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12607692/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12607692/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12607692/full.md

---
Source: https://tomesphere.com/paper/PMC12607692